Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model.

Goswami R, Nelson AN, Tu JJ, Dennis M, Feng L, Kumar A, Mangold J, Mangan RJ, Mattingly C, Curtis AD 2nd, Obregon-Perko V, Mavigner M, Pollara J, Shaw GM, Bar KJ, Chahroudi A, De Paris K, Chan C, Van Rompay KKA, Permar SR.

MBio. 2019 Sep 5;10(5). pii: e01971-19. doi: 10.1128/mBio.01971-19.

2.

Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes.

Nelson AN, Goswami R, Dennis M, Tu J, Mangan RJ, Saha PT, Cain DW, Curtis AD, Shen X, Shaw GM, Bar K, Hudgens M, Pollara J, De Paris K, Van Rompay KKA, Permar SR.

J Virol. 2019 Jul 17;93(15). pii: e00168-19. doi: 10.1128/JVI.00168-19. Print 2019 Aug 1.

PMID:
31092583
3.
4.

Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques.

Dennis M, Eudailey J, Pollara J, McMillan AS, Cronin KD, Saha PT, Curtis AD, Hudgens MG, Fouda GG, Ferrari G, Alam M, Van Rompay KKA, De Paris K, Permar S, Shen X.

J Virol. 2019 Feb 19;93(5). pii: e01783-18. doi: 10.1128/JVI.01783-18. Print 2019 Mar 1.

5.

Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant Macaques.

Curtis AD 2nd, Walter KA, Nabi R, Jensen K, Dwivedi A, Pollara J, Ferrari G, Van Rompay KKA, Amara RR, Kozlowski PA, De Paris K.

AIDS Res Hum Retroviruses. 2019 Mar;35(3):310-325. doi: 10.1089/AID.2018.0180. Epub 2018 Nov 27.

PMID:
30303405
6.

A simultaneous oral and intramuscular prime/sublingual boost with a DNA/Modified Vaccinia Ankara viral vector-based vaccine induces simian immunodeficiency virus-specific systemic and mucosal immune responses in juvenile rhesus macaques.

Curtis AD 2nd, Jensen K, Van Rompay KKA, Amara RR, Kozlowski PA, De Paris K.

J Med Primatol. 2018 Oct;47(5):288-297. doi: 10.1111/jmp.12372. Epub 2018 Sep 11.

PMID:
30204253
7.

Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy.

Oluwasanmi A, Al-Shakarchi W, Manzur A, Aldebasi MH, Elsini RS, Albusair MK, Haxton KJ, Curtis ADM, Hoskins C.

J Control Release. 2017 Nov 28;266:355-364. doi: 10.1016/j.jconrel.2017.09.027. Epub 2017 Sep 22.

PMID:
28943195
8.

Impact of Poxvirus Vector Priming, Protein Coadministration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques.

Phillips B, Fouda GG, Eudailey J, Pollara J, Curtis AD 2nd, Kunz E, Dennis M, Shen X, Bay C, Hudgens M, Pickup D, Alam SM, Ardeshir A, Kozlowski PA, Van Rompay KKA, Ferrari G, Moody MA, Permar S, De Paris K.

Clin Vaccine Immunol. 2017 Oct 5;24(10). pii: e00231-17. doi: 10.1128/CVI.00231-17. Print 2017 Oct.

9.
10.

Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.

Patial S, Curtis AD 2nd, Lai WS, Stumpo DJ, Hill GD, Flake GP, Mannie MD, Blackshear PJ.

Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1865-70. doi: 10.1073/pnas.1519906113. Epub 2016 Feb 1.

11.

Automated analysis of flow cytometric data for measuring neutrophil CD64 expression using a multi-instrument compatible probability state model.

Wong L, Hill BL, Hunsberger BC, Bagwell CB, Curtis AD, Davis BH.

Cytometry B Clin Cytom. 2015 Jul-Aug;88(4):227-35. doi: 10.1002/cyto.b.21217. Epub 2015 Feb 6.

12.

The extracellular domain of myelin oligodendrocyte glycoprotein elicits atypical experimental autoimmune encephalomyelitis in rat and Macaque species.

Curtis AD 2nd, Taslim N, Reece SP, Grebenciucova E, Ray RH, Rosenbaum MD, Wardle RL, Van Scott MR, Mannie MD.

PLoS One. 2014 Oct 10;9(10):e110048. doi: 10.1371/journal.pone.0110048. eCollection 2014. Erratum in: PLoS One. 2015;10(2):e0117878.

13.
14.

Laser-driven flyer plates for shock compression science: launch and target impact probed by photon Doppler velocimetry.

Curtis AD, Banishev AA, Shaw WL, Dlott DD.

Rev Sci Instrum. 2014 Apr;85(4):043908. doi: 10.1063/1.4871361.

PMID:
24784627
15.

Simulated drug discovery process to conduct a synoptic assessment of pharmacy students.

Richardson A, Curtis AD, Moss GP, Pearson RJ, White S, Rutten FJ, Perumal D, Maddock K.

Am J Pharm Educ. 2014 Mar 12;78(2):41. doi: 10.5688/ajpe78241.

16.

Preclinical evaluation of statins as a treatment for ovarian cancer.

Robinson E, Nandi M, Wilkinson LL, Arrowsmith DM, Curtis AD, Richardson A.

Gynecol Oncol. 2013 May;129(2):417-24. doi: 10.1016/j.ygyno.2013.02.003. Epub 2013 Feb 8.

PMID:
23402903
17.

Tolerogenic vaccines for Multiple sclerosis.

Mannie MD, Curtis AD 2nd.

Hum Vaccin Immunother. 2013 May;9(5):1032-8. doi: 10.4161/hv.23685. Epub 2013 Jan 28.

18.

Physical activity is not play: perceptions of children and parents from deprived areas.

Curtis AD, Hinckson EA, Water TC.

N Z Med J. 2012 Nov 9;125(1365):38-47.

PMID:
23254499
19.

Plasma treatment of polystyrene thin films affects more than the surface.

Calchera AR, Curtis AD, Patterson JE.

ACS Appl Mater Interfaces. 2012 Jul 25;4(7):3493-9. doi: 10.1021/am300585a. Epub 2012 Jul 5.

PMID:
22642391
20.

Role of nonresonant sum-frequency generation in the investigation of model liquid chromatography systems.

Quast AD, Curtis AD, Horn BA, Goates SR, Patterson JE.

Anal Chem. 2012 Feb 21;84(4):1862-70. doi: 10.1021/ac2032035. Epub 2012 Feb 3.

PMID:
22264066
21.
22.

An international standard for low molecular weight heparin.

Barrowcliffe TW, Curtis AD, Johnson EA, Thomas DP.

Thromb Haemost. 1988 Aug 30;60(1):1-7.

PMID:
2847351
23.
24.

Bioavailability in rats of human recombinant tissue plasminogen activator after subcutaneous and intramuscular injection.

Garcia Frade LJ, Poole S, Hanley S, Creighton LJ, Curtis AD, Gaffney PJ.

Thromb Haemost. 1986 Dec 15;56(3):299-301.

PMID:
3105106
25.

Assay of factor VIII concentrates: comparison of the chromogenic and two-stage clotting assays.

Hubbard AR, Curtis AD, Barrowcliffe TW, Edwards SJ, Jennings CA, Kemball-Cook G.

Thromb Res. 1986 Dec 15;44(6):887-91. No abstract available.

PMID:
3099425
26.

Low molecular weight heparin: a better drug?

Thomas DP, Barrowcliffe TW, Curtis AD.

Haemostasis. 1986;16(2):87-92.

PMID:
3710298
27.

British standard for human serum vitamin B12.

Curtis AD, Mussett MV, Kennedy DA.

Clin Lab Haematol. 1986;8(2):135-47.

PMID:
3089675
28.

Standardization of low molecular weight heparins: a collaborative study.

Barrowcliffe TW, Curtis AD, Tomlinson TP, Hubbard AR, Johnson EA, Thomas DP.

Thromb Haemost. 1985 Oct 30;54(3):675-9.

PMID:
4089797
29.

Standardization of prekallikrein activator (PKA): the 1st International Standard for PKA.

Kerry PJ, Curtis AD, Thomas DP.

Br J Haematol. 1985 Jun;60(2):345-52.

PMID:
3873958
30.

A collaborative study of a proposed international standard for tissue plasminogen activator (t-PA).

Gaffney PJ, Curtis AD.

Thromb Haemost. 1985 Feb 18;53(1):134-6.

PMID:
4039472
31.
33.

A collaborative study designed to establish the 4th International Standard for Heparin.

Thomas DP, Curtis AD, Barrowcliffe TW.

Thromb Haemost. 1984 Oct 31;52(2):148-53.

PMID:
6523431
34.

The establishment of a standard for plasminogen (glu-type).

Gaffney PJ, Curtis AD.

Thromb Haemost. 1984 Jul 29;51(3):376-8.

PMID:
6238442
35.

The statistical evaluation of Factor VIII clotting assays.

Curtis AD.

Scand J Haematol Suppl. 1984;41:55-68. Review. No abstract available.

PMID:
6440286
36.

The stability of tissue plasminogen activator (t-PA).

Gaffney PJ, Templeman J, Curtis AD, Campbell PJ.

Thromb Haemost. 1983 Oct 31;50(3):650-1.

PMID:
6685926
37.

Standardization of Factor VIII-IV. Establishment of the 3rd International Standard for Factor VIII: C concentrate.

Barrowcliffe TW, Curtis AD, Thomas DP.

Thromb Haemost. 1983 Oct 31;50(3):697-702.

PMID:
6417819
39.

Factor VIII standardisation.

Barrowcliffe TW, Tydeman MS, Curtis AD, Thomas DP, Kirkwood TB.

Lancet. 1983 Jan 1;1(8314-5):62. No abstract available.

PMID:
6129388
40.

Standardization of prekallikrein activator (PKA): the 1st British reference preparation for PKA.

Kerry PJ, Curtis AD, Paton CJ, Thomas DP.

Br J Haematol. 1982 Oct;52(2):275-81.

PMID:
6982063

Supplemental Content

Loading ...
Support Center